{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:33:08Z","timestamp":1773797588577,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.05.096","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T09:47:40Z","timestamp":1370857660000},"page":"3485-3491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Live attenuated tularemia vaccines: Recent developments and future goals"],"prefix":"10.1016","volume":"31","author":[{"given":"Mark E.","family":"Marohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.096_bib0005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/MMBR.30.3.532-538.1966","article-title":"Aerogenic immunization of man with live Tularemia vaccine","volume":"30","author":"Hornick","year":"1966","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1409.009","article-title":"Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations","volume":"1105","author":"Sjostedt","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrmicro1045","article-title":"Tularaemia: bioterrorism defence renews interest in Francisella tularensis","volume":"2","author":"Oyston","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archinte.1961.03620050068007","article-title":"Tularemia vaccine study. II. Respiratory challenge","volume":"107","author":"Saslaw","year":"1961","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/MMBR.25.3.262-267.1961","article-title":"Aerosol infection of man with Pasteurella tularensis","volume":"25","author":"McCrumb","year":"1961","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1196\/annals.1409.012","article-title":"Vaccines against Francisella tularensis","volume":"1105","author":"Wayne Conlan","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.05.096_bib0035","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1086\/518150","article-title":"From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia research","volume":"45","author":"Cross","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2105\/AJPH.32.10.1131","article-title":"Vaccine prophylaxis against tularemia in man","volume":"32","author":"Foshay","year":"1942","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/infdis\/135.1.55","article-title":"Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia","volume":"135","author":"Burke","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0050","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.vaccine.2009.06.036","article-title":"Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans","volume":"27","author":"El Sahly","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0055","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.vaccine.2008.01.005","article-title":"An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes","volume":"26","author":"Pasetti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0060","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0264-410X(95)00062-6","article-title":"Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia","volume":"13","author":"Fulop","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0065","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/IAI.60.7.2855-2862.1992","article-title":"Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium","volume":"60","author":"Sjostedt","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0070","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1128\/IAI.59.9.2922-2928.1991","article-title":"Live vaccine strain of Francisella tularensis: infection and immunity in mice","volume":"59","author":"Fortier","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0882-4010(03)00046-9","article-title":"Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies","volume":"34","author":"Conlan","year":"2003","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0080","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1128\/IAI.00666-06","article-title":"Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain","volume":"74","author":"Pechous","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0085","doi-asserted-by":"crossref","first-page":"e2487","DOI":"10.1371\/journal.pone.0002487","article-title":"A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge","volume":"3","author":"Pechous","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0090","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/IAI.01717-06","article-title":"Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG","volume":"75","author":"Lindgren","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0095","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.vaccine.2009.02.073","article-title":"Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes","volume":"27","author":"Santiago","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0100","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1128\/IAI.00192-10","article-title":"A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge","volume":"78","author":"Jia","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1099\/jmm.0.018911-0","article-title":"Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularaemia","volume":"59","author":"Michell","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0110","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2009.12.001","article-title":"Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization","volume":"28","author":"Conlan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0115","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/infdis\/jir620","article-title":"Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine","volume":"205","author":"Kim","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0120","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.vaccine.2004.10.034","volume":"23","author":"Wayne Conlan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2180-11-179","article-title":"A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia","volume":"11","author":"Jayakar","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0130","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/IAI.00144-12","article-title":"Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis","volume":"80","author":"Marohn","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0135","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/IAI.00503-10","article-title":"The fslE homolog, FTL_0439 (fupA\/B), mediates siderophore-dependent iron uptake in Francisella tularensis LVS","volume":"78","author":"Sen","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0140","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1128\/IAI.00135-11","article-title":"A Francisella tularensis locus required for spermine responsiveness is necessary for virulence","volume":"79","author":"Russo","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/IAI.00991-12","article-title":"Francisella tularensis LVS folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation","volume":"81","author":"Ulland","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0150","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1016\/j.vaccine.2008.07.051","article-title":"An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain","volume":"26","author":"Bakshi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0155","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1016\/j.vaccine.2012.03.036","volume":"30","author":"Twine","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0160","doi-asserted-by":"crossref","first-page":"e13349","DOI":"10.1371\/journal.pone.0013349","article-title":"Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy","volume":"5","author":"Shen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2012.10.043","article-title":"Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria","volume":"54","author":"Ryden","year":"2012","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0170","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1099\/mic.0.052902-0","article-title":"A Francisella tularensis SCHU S4 mutant deficient in gamma-glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate","volume":"157","author":"Ireland","year":"2011","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0175","doi-asserted-by":"crossref","first-page":"e37752","DOI":"10.1371\/journal.pone.0037752","article-title":"Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination","volume":"7","author":"Rockx-Brouwer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/IAI.01113-08","article-title":"Identification of an essential Francisella tularensis subsp. tularensis virulence factor","volume":"77","author":"Qin","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0185","doi-asserted-by":"crossref","first-page":"e24611","DOI":"10.1371\/journal.pone.0024611","article-title":"Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis","volume":"6","author":"Qin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0190","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.4049\/jimmunol.180.10.6885","article-title":"Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways","volume":"180","author":"Cole","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0195","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.micinf.2008.04.008","article-title":"Inhalation of Francisella novicida Delta mglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia","volume":"10","author":"West","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0200","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.4049\/jimmunol.176.11.6888","article-title":"Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity","volume":"176","author":"Cole","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0205","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/IAI.01868-06","article-title":"Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages","volume":"75","author":"Cole","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0210","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.181.6.4159","article-title":"Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism","volume":"181","author":"Shirey","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1574-695X.1996.tb00244.x","article-title":"Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis","volume":"13","author":"Golovliov","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0220","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/IAI.63.2.534-538.1995","article-title":"Cytokine expression in the liver during the early phase of murine tularemia","volume":"63","author":"Golovliov","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.282.2.137","article-title":"Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial","volume":"282","author":"Nichol","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0230","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/biol.1997.0103","article-title":"Alternative routes of measles immunization: a review","volume":"25","author":"Cutts","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4161\/hv.1.1.1423","article-title":"A meta-analysis of studies comparing the respiratory route with the subcutaneous route of measles vaccine administration","volume":"1","author":"Hiremath","year":"2005","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0240","first-page":"165","article-title":"Measles aerosol vaccination","volume":"304","author":"Valdespino-Gomez","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0245","first-page":"63","article-title":"A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali","volume":"76","author":"Perry","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0250","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/jps.22563","article-title":"Formulation and stabilization of Francisella tularensis live vaccine strain","volume":"100","author":"Ohtake","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1409.003","article-title":"Animal models of Francisella tularensis infection","volume":"1105","author":"Rick Lyons","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0260","doi-asserted-by":"crossref","first-page":"e24654","DOI":"10.1371\/journal.pone.0024654","article-title":"Pneumonic tularemia in rabbits resembles the human disease as illustrated by radiographic and hematological changes after infection","volume":"6","author":"Reed","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0265","doi-asserted-by":"crossref","first-page":"e9952","DOI":"10.1371\/journal.pone.0009952","article-title":"The Fischer 344 rat reflects human susceptibility to Francisella pulmonary challenge and provides a new platform for virulence and protection studies","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0270","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1016\/j.vaccine.2009.05.060","article-title":"Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0275","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1099\/jmm.0.020669-0","article-title":"Characterization of lethal inhalational infection with Francisella tularensis in the common marmoset (Callithrix jacchus)","volume":"59","author":"Nelson","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2613.2008.00631.x","article-title":"Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus)","volume":"90","author":"Nelson","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0285","series-title":"Abstracts of the 7th International Conference on Tularemia","article-title":"Tularemia vaccine trials in nonhuman primates","author":"Tempel","year":"2012"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0290","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/clinids\/11.3.440","article-title":"Nature of protective immunity to Francisella tularensis","volume":"11","author":"Tarnvik","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0295","doi-asserted-by":"crossref","first-page":"e33349","DOI":"10.1371\/journal.pone.0033349","article-title":"Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia","volume":"7","author":"Crane","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0300","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/IAI.01249-12","article-title":"Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection","volume":"81","author":"Kurtz","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1409.011","article-title":"Molecular epidemiology, evolution, and ecology of Francisella","volume":"1105","author":"Keim","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0310","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3201\/eid1207.051504","article-title":"Epidemiologic and molecular analysis of human tularemia, United States, 1964\u20132004","volume":"12","author":"Staples","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0315","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.1128\/IAI.73.12.8345-8352.2005","article-title":"A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine","volume":"73","author":"Twine","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0320","doi-asserted-by":"crossref","first-page":"12897","DOI":"10.1073\/pnas.0602582103","article-title":"Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence","volume":"103","author":"Gil","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0325","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1128\/JB.00266-06","article-title":"Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence","volume":"188","author":"Bakshi","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0330","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/IAI.01429-06","article-title":"Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity","volume":"75","author":"Raynaud","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0335","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/IAI.01789-06","article-title":"A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity","volume":"75","author":"Sebastian","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0340","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1099\/mic.0.2007\/006460-0","article-title":"Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS","volume":"153","author":"Li","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0345","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/IAI.01726-07","article-title":"Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence","volume":"76","author":"Chakraborty","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0350","doi-asserted-by":"crossref","first-page":"e1000284","DOI":"10.1371\/journal.ppat.1000284","article-title":"Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis","volume":"5","author":"Alkhuder","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2180-6-69","article-title":"Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2","volume":"6","author":"Qin","year":"2006","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.096_bib0360","series-title":"Abstracts of the 7th International Conference on Tularemia","article-title":"A highly protective type A-based live attenuated F. tularensis vaccine","author":"Mann","year":"2012"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300724X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300724X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T03:10:35Z","timestamp":1595905835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1300724X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":72,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X1300724X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.096","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated tularemia vaccines: Recent developments and future goals","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}